Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4786201 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4 | |
| SCHEMBL4736688 | 0.88 | FFAR1 (0.67) | FFAR1FFAR4 | |
| SCHEMBL4681590 | 0.88 | FFAR1 (0.67) | FFAR1FFAR4 | |
| SCHEMBL4739724 | 0.80 | FFAR1 (0.61) | FFAR1FFAR4 | |
| SCHEMBL4739732 | 0.80 | FFAR1 (0.61) | FFAR1FFAR4 | |
| SCHEMBL13118297 | 0.79 | FFAR1 (0.71) | FFAR1FFAR4 | |
| SCHEMBL4684935 | 0.79 | FFAR1 (0.66) | FFAR1FFAR4 | |
| SCHEMBL4804081 | 0.79 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL4804068 | 0.79 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL4684942 | 0.79 | FFAR1 (0.66) | FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893582-A2 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE IN TREATING METABOLIC DISORDERS | Amgen, Inc (US) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006127503-A2 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE IN TREATING METABOLIC DISORDERS | AMGEN INC (US) | 2006-11-30 | — | — | WO | disclosed |